PERSON
Novo Nordisk’s Wegovy Pill Launches Strongly Amid Analyst Caution
Wegovy pill; Novo Nordisk; FDA approval; oral GLP-1; obesity drug; Eli Lilly competition
Hua Medicine Advances Dorzagliatin Expansion Beyond China with Hong Kong NDA Acceptance
Hua Medicine; dorzagliatin; diabetes drug; China expansion; Hong Kong NDA; Southeast Asia; glucokinase activator
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
MBX Biosciences; Laurie Stelzer; Board Appointment; Audit Committee; Independent Director
IntraBio’s Levacetylleucine Succeeds in Phase 3 Trial for Ataxia-Telangiectasia, Plans FDA and EMA Approval
IntraBio; levacetylleucine; Ataxia-Telangiectasia; Phase 3; FDA approval; EMA; rare disease
Angelini Pharma Appoints Sergio Marullo di Condojanni as New CEO
Angelini Pharma; Sergio Marullo di Condojanni; CEO Appointment; Angelini Industries
Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
Rentschler Biopharma; Executive Board Changes; Interim CEO; Corporate Strategy; Uwe Buecheler; Benedikt von Braunmuehl; Christiane Bardroff
Moderna and Merck Report Sustained 49% Risk Reduction in Recurrence or Death with mRNA-Keytruda Combo at Five Years in Melanoma Trial
Moderna; Merck; Keytruda; intisemeran autogene; mRNA-4157; melanoma; recurrence-free survival; Phase 2b
Makary Proposes Higher FDA User Fees for Non-US Phase I Trials to Counter China Biotech
Makary; FDA; user fees; China; biotech; Phase I trials; America First
AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Trial of AAVB-081 for Usher Syndrome Type 1B-Associated Retinitis Pigmentosa
AAVantgarde; LUCE-1; AAVB-081; Usher Syndrome Type 1B; USH1B; retinitis pigmentosa; gene therapy; clinical trial
Genmab and AbbVie’s Epcoritamab Misses Overall Survival Endpoint but Meets PFS in Phase 3 DLBCL Trial
Genmab; AbbVie; epcoritamab; Epkinly; EPCORE DLBCL-1; Phase 3; DLBCL; lymphoma; overall survival; progression-free survival